Yi Lin

74PUBLICATIONS
304CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Aug 14, 2026
Review Article: Immune Effector Cell-Mediated Enterocolitis Following CAR-T Cell Therapy-Clinical Features, Pathophysiology and Management.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jun 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

|Apr 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

Pageof 13

Frequent Collaborators

38 joint publications

Shaji Kumar

37 joint publications

Prashant Kapoor

35 joint publications

Taxiarchis V Kourelis

32 joint publications

Moritz Binder